Joe Rafferty
Chief Executive
NHS Central Lancashire
Joe Rafferty is currently Chief Executive of NHS Central Lancashire. The organisation has an annual commissioning budget of £750M for a resident population of 480,000 people across a mixed geography of 450 sq miles.
Previously he was regional Director of Commissioning and Strategy for NHS North West from 2006-2008, the most complex SHA in England. During this time, he was one of the principle architects of the World Class Commissioning Assurance system, in which the 24 PCTs in the north west collectively performed in the upper quartile of organisations nationally. While regional director, he also worked to develop a set of strategic scenarios for the future of healthcare that were used by DH for the 'Darzi Review' and have been used by a variety of international healthcare systems.
Other Board level roles have included Director of Performance in Cumbria and Lancashire SHA and Director of System Reform at Bolton Hospital NHS Trust. Prior to these he was part of the team that set up Greater Manchester SHA.
Joe has worked in advisory roles with the English Department of Health on issues ranging from Choice and Plurality, Diagnostics and 18 weeks.
Before joining the NHS in 1999 as a National Trainee on the General Management Training Scheme, Joe worked as a team leader in molecular genetics at the Paterson Institute for Cancer Research in Manchester and before that at Strangeway's Research Laboratory in Cambridge.
He graduated from The Queen's University of Belfast in 1987 with a Ph.D in genetics.
Other Board level roles have included Director of Performance in Cumbria and Lancashire SHA and Director of System Reform at Bolton Hospital NHS Trust. Prior to these he was part of the team that set up Greater Manchester SHA.
Joe has worked in advisory roles with the English Department of Health on issues ranging from Choice and Plurality, Diagnostics and 18 weeks.
Before joining the NHS in 1999 as a National Trainee on the General Management Training Scheme, Joe worked as a team leader in molecular genetics at the Paterson Institute for Cancer Research in Manchester and before that at Strangeway's Research Laboratory in Cambridge.
He graduated from The Queen's University of Belfast in 1987 with a Ph.D in genetics.
